Q-Linea
Develops rapid, automated antimicrobial susceptibility testing for critical infections.
QLINEA | ST
Overview
Corporate Details
- ISIN(s):
- SE0011527845 (+2 more)
- LEI:
- 549300BXVB4XRM8WSC73
- Country:
- Sweden
- Address:
- Dag Hammarskjölds väg 52A, 752 37 Uppsala
- Website:
- https://www.qlinea.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of irradiation, electromedical and electrotherapeutic equipment
Description
Q-linea is an innovative infection diagnostics company dedicated to developing solutions for time-critical, life-threatening infections like sepsis and combating the global threat of antimicrobial resistance. The company's flagship product is ASTar®, a fully automated system that provides rapid phenotypic Antimicrobial Susceptibility Testing (AST). By significantly reducing the time to diagnosis from days to hours, ASTar enables healthcare providers to make faster, more accurate treatment decisions with targeted antibiotics. This improves patient outcomes, saves lives, and helps reduce healthcare costs. The ASTar system, which has been granted Breakthrough Device designation by the U.S. FDA, is designed for use in clinical laboratories to optimize the diagnostic workflow for infectious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-23 12:56 |
Major Shareholding Notification
|
Swedish | 10.9 KB | ||
| 2025-09-18 08:10 |
Pre-Annual General Meeting Information
KALLELSE TILL EXTRA BOLAGSSTÄMMA I Q-LINEA AB (PUBL)
|
Swedish | 72.1 KB | ||
| 2025-09-18 08:10 |
Pre-Annual General Meeting Information
NOTICE OF EXTRAORDINARY GENERAL MEETING IN Q-LINEA AB (PUBL)
|
English | 73.3 KB | ||
| 2025-09-18 08:00 |
Share Issue/Capital Change
Q-linea resolves to carry out a rights issue of approximately SEK 322 million a…
|
English | 78.6 KB | ||
| 2025-09-18 08:00 |
Share Issue/Capital Change
Q-linea beslutar att genomföra en företrädesemission om cirka 322 MSEK och offe…
|
Swedish | 78.0 KB | ||
| 2025-09-10 19:51 |
Legal Proceedings Report
Uppdatering om ESTAR-upphandlingen för snabb AST
|
Swedish | 50.4 KB | ||
| 2025-09-10 19:51 |
Legal Proceedings Report
Update on ESTAR tender for rapid AST
|
English | 49.8 KB | ||
| 2025-09-03 11:19 |
Major Shareholding Notification
|
Swedish | 10.9 KB | ||
| 2025-09-02 11:28 |
Major Shareholding Notification
|
Swedish | 10.9 KB | ||
| 2025-08-25 13:13 |
Major Shareholding Notification
|
Swedish | 10.9 KB | ||
| 2025-08-21 14:04 |
Major Shareholding Notification
|
Swedish | 10.9 KB | ||
| 2025-07-31 08:30 |
Declaration of Voting Results & Voting Rights Announcements
Förändrat antal aktier och röster i Q-linea AB (publ)
|
Swedish | 50.4 KB | ||
| 2025-07-31 08:30 |
Declaration of Voting Results & Voting Rights Announcements
New number of shares and votes in Q-linea AB (publ)
|
English | 50.7 KB | ||
| 2025-07-10 07:30 |
Interim Report
|
Swedish | 778.5 KB | ||
| 2025-07-10 07:30 |
Interim Report
|
English | 911.4 KB |
Automate Your Workflow. Get a real-time feed of all Q-Linea filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Q-Linea via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2020-03-13 | QUANG THONG NGO | Other | Buy | 4,500 | 2,178,000.00 EUR |
| 2020-03-13 | Thomas Fritz | Other | Buy | 4,500 | 21,780.00 EUR |
